Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: A case report

International Journal of Gynecological Cancer

Volumn 15, Issue 6, 2005, Pages 1187-1190

  Nagai, Nobutaka ^a   Hirata, E ^a   Kusuda, T ^a   Mukai, K ^a   Arihiro, K ^b   Ohama, K ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Docetaxel and cisplatin; Neoadjuvant chemotherapy; Villoglandular papillary adenocarcinoma

Indexed keywords

CISPLATIN; DOCETAXEL; TUMOR MARKER;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; ANAMNESIS; ARTICLE; CANCER SCREENING; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPANICOLAOU TEST; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENT DISEASE; THORAX RADIOGRAPHY; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX VILLOGLANDULAR PAPILLARY ADENOCARCINOMA;

ADENOCARCINOMA, PAPILLARY; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; TAXOIDS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 30944443926     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00186.x     Document Type: Article

References (18)

1. Fu YS, Reagan JW, Hsui JG, Storaasli JP, Wentz WB. Adenocarcinoma and mixed carcinoma of the uterine cervix: a clinicopathologic study. Cancer 1982;49:2560-70.
2. Moberg PJ, Einhorn N, Silverward C, Soderberg G. Adenocarcinoma of uterine cervix. Cancer 1986;57:407-10.
3. Park RC, Thigpen JT. Chemotherapy in advanced and recurrent cervical cancer: a review. Cancer 1993;71:1446-50.
4. Umesaki N, Izumi R, Fushiki H et al. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin c, etoposide, and cisplatin for advanced or recurrent disease. Gynecol Oncol 1999;75: 142-4.
5. Kavanagh JJ, Gershenson D, Copeland L, Robert WAS. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol 1987;5:1621-33.
6. Young RH, Scully RE. Villograndular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 1989;63:1773-9.
7. Kaku T, Kamura T, Shigematus T et al. Adenocarcinoma of the uterine cervix with predominantly villoglandular papillary growth pattern. Gynecol Oncol 1997;64:147-52.
8. Collinet P, Prolongeau JF, Vaneecloo S. Villoglandular papillary adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1999;86:101-3.
9. Japan Society of Obstetrics and Gynecology, The Japanese Society of Pathology, Japan Radiological Society. The general rules for clinical and pathological management of uterine cervical cancer, 2nd edn. Tokyo: Kanahara, 1997.
10. Kudelka AP, Winn R, Edwards CL et al. Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Clin Cancer Res 1996;2:1285-8.
11. Curtin JP, Blessing JA, Webster KD et al. Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2001;19:1275-8.
12. Piver MS, Ghamande SA, Eltabbalch GH, O'Neill-Coppola C. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix-a phase II study. Gynecol Oncol 1999; 75:334-7.
13. Vallejo C, Machiavelli MR, Pérez JE et al. Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma. Am J Clin Oncol 2003;26:477-82.
14. Rein DT, Karbacher CM, Breindenbach M et al. Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study. Gynecol Oncol 2002;87:98-103.
15. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7.
16. Hopson L, Jones MA, Boyce CR, Tarraza HM Jr. Papillary villoglandular carcinoma of the cervix. Gynecol Oncol 1990;39:221-4.
17. Reed W, Abeler VW, Trope CG. Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis? Tidsskr Nor Laegeforen 1993;113:2569-71.
18. Costa MJ, McIlnay KR, Trelford J. Cercical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol 1995;26:829-37.